FOLH1 and prostate carcinoma: Importantly, prostate-specific membrane antigen (PSMA), a well-known target in prostate cancer, is not expressed in non-prostate tumors nor in healthy vasculature, but is expressed in the endothelial cells of tumor-associated neovasculature (137).